Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 4, 2015, Pages 394-403.e1

  Bangen, Katherine J ^a   Nation, Daniel A ^b   Delano Wood, Lisa ^a,b   Weissberger, Gali H ^c   Hansen, Lawrence A ^d,e   Galasko, Douglas R ^b,d   Salmon, David P ^d   Bondi, Mark W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Dementia; Neuropathology; Vascular risk

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; BRAIN CIRCULUS ARTERIOSUS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; ADULT; AGED; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; SMOKING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SMOKING;

EID: 84927177527     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.12.025     Document Type: Article

References (51)

1. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 2005 545 551
2. R.A. Whitmer, S. Sidney, J. Selby, S.C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2005 277 281
3. J. Genest Jr., and J.S. Cohn Clustering of cardiovascular risk factors: targeting high-risk individuals Am J Cardiol 76 1995 8A 20A
4. M. Szklo, and F. Nieto Epidemiology: beyond the basics 2000 Aspen Publishers Gaithersburg, Maryland
5. H.C. Chui, L. Zheng, B.R. Reed, H.V. Vinters, and W.J. Mack Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review Alzheimers Res Ther 4 2012 1
6. T.G. Beach, J.R. Wilson, L.I. Sue, A. Newell, M. Poston, and R. Cisneros Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles Acta Neuropathol 113 2007 13 21
7. A.E. Roher, C. Esh, T.A. Kokjohn, W. Kalback, D.C. Luehrs, and J.D. Seward Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease Arterioscler Thromb Vasc Biol 23 2003 2055 2062
8. M. Yarchoan, S.X. Xie, M.A. Kling, J.B. Toledo, D.A. Wolk, and E.B. Lee Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias Brain 135 Pt 12 2012 3749 3756
9. J.A. Schneider, N.T. Aggarwal, L. Barnes, P. Boyle, and D.A. Bennett The neuropathology of older persons with and without dementia from community versus clinic cohorts J Alzheimers Dis 18 2009 691 701
10. J.A. Schneider, Z. Arvanitakis, W. Bang, and D.A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology 69 2007 2197 2204
11. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, and L.M. Brownlee The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
12. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Neurobiol Aging 18 4 Suppl 1997 S1 S2
13. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
14. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
15. K.J. Bangen, A. Beiser, L. Delano-Wood, D.A. Nation, M. Lamar, and D.J. Libon APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline J Stroke Cerebrovasc Dis 22 2013 1361 1369
16. R.B. D'Agostino, P.A. Wolf, A.J. Belanger, and W.B. Kannel Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study Stroke 25 1994 40 43
17. J.D. Berry, A. Dyer, X. Cai, D.B. Garside, H. Ning, and A. Thomas Lifetime risks of cardiovascular disease N Engl J Med 366 2012 321 329
18. D.M. Lloyd-Jones, E.P. Leip, M.G. Larson, R.B. D'Agostino, A. Beiser, and P.W. Wilson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
19. L.A. Hansen, and W. Samuel Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies Neurology 48 1997 126 132
20. D.A. Nation, L. Delano-Wood, K.J. Bangen, C.E. Wierenga, A.J. Jak, and L.A. Hansen Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease J Alzheimers Dis 30 2012 595 603
21. W. Samuel, D. Galasko, E. Masliah, and L.A. Hansen Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease J Neuropathol Exp Neurol 55 1996 44 52
22. H. Braak, and E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
23. M. Gearing, S.S. Mirra, J.C. Hedreen, S.M. Sumi, L.A. Hansen, and A. Heyman The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease Neurology 45 3 Pt 1 1995 461 466
24. J.M. Olichney, L.A. Hansen, D. Galasko, T. Saitoh, C.R. Hofstetter, and R. Katzman The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant Neurology 47 1996 190 196
25. R.Y. Lo, and W.J. Jagust Vascular burden and Alzheimer disease pathologic progression Neurology 79 2012 1349 1355
26. A.Y. Lee, S.H. Jeong, B.H. Choi, E.H. Sohn, and H. Chui Pulse pressure correlates with leukoaraiosis in Alzheimer disease Arch Gerontol Geriatr 42 2006 157 166
27. B.V. Zlokovic, R. Deane, J. Sallstrom, N. Chow, and J.M. Miano Neurovascular pathways and Alzheimer amyloid beta-peptide Brain Pathol 15 2005 78 83
28. M.S. Beeri, M. Rapp, J.M. Silverman, J. Schmeidler, H.T. Grossman, and J.T. Fallon Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology 66 2006 1399 1404
29. L.S. Honig, W. Kukull, and R. Mayeux Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center Neurology 64 2005 494 500
30. N.L. Marchant, B.R. Reed, N. Sanossian, C.M. Madison, S. Kriger, and R. Dhada The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction JAMA Neurol 70 2013 488 495
31. B.R. Reed, N.L. Marchant, W.J. Jagust, C.C. DeCarli, W. Mack, and H.C. Chui Coronary risk correlates with cerebral amyloid deposition Neurobiol Aging 33 2012 1979 1987
32. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, and P.S. Aisen Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
33. M.M. Esiri, Z. Nagy, M.Z. Smith, L. Barnetson, and A.D. Smith Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease Lancet 354 1999 919 920
34. J.B. Toledo, S.E. Arnold, K. Raible, J. Brettschneider, S.X. Xie, and M. Grossman Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre Brain 136 Pt 9 2013 2697 2706
35. C. DeCarli, J. Massaro, D. Harvey, J. Hald, M. Tullberg, and R. Au Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal Neurobiol Aging 26 2005 491 510
36. P.A. Wolf, R.B. D'Agostino, A.J. Belanger, and W.B. Kannel Probability of stroke: a risk profile from the Framingham Study Stroke 22 1991 312 318
37. C. DeCarli Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals J Alzheimers Dis 33 Suppl 1 2013 S417 S426
38. P.B. Gorelick, A. Scuteri, S.E. Black, C. Decarli, S.M. Greenberg, and C. Iadecola Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 2672 2713
39. W.J. Jagust, L. Zheng, D.J. Harvey, W.J. Mack, H.V. Vinters, and M.W. Weiner Neuropathological basis of magnetic resonance images in aging and dementia Ann Neurol 63 2008 72 80
40. C. Qiu, B. Winblad, and L. Fratiglioni The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 2005 487 499
41. A.M. Tolppanen, A. Solomon, H. Soininen, and M. Kivipelto Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies J Alzheimers Dis 32 2012 531 540
42. R. Au, S. Seshadri, K. Knox, A. Beiser, J.J. Himali, and H.J. Cabral The Framingham Brain Donation Program: neuropathology along the cognitive continuum Curr Alzheimer Res 9 2012 673 686
43. A.M. Brickman, F.A. Provenzano, J. Muraskin, J.J. Manly, S. Blum, and Z. Apa Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community Arch Neurol 2012 1 7
44. G.M. McKhann, M.S. Albert, M. Grossman, B. Miller, D. Dickson, and J.Q. Trojanowski Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol 58 2001 1803 1809
45. H. Braak, E. Ghebremedhin, U. Rub, H. Bratzke, and K. Del Tredici Stages in the development of Parkinson's disease-related pathology Cell Tissue Res 318 2004 121 134
46. N.J. Cairns, E.H. Bigio, I.R. Mackenzie, M. Neumann, V.M. Lee, and K.J. Hatanpaa Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 2007 5 22
47. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch Neurol 56 1999 33 39
48. I.R. Mackenzie, M. Neumann, E.H. Bigio, N.J. Cairns, I. Alafuzoff, and J. Kril Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations Acta Neuropathol 117 2009 15 18
49. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, and H. Feldman Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 2005 1863 1872
50. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, and L.A. Hansen Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
51. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, and J.H. Garcia Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260